This opportunity is no longer accepting applications.
grant CDC/NCEZID 033

Rapid, Portable, Point-of-Care Carbapenem Resistant Acinetobacter Colonization Screening Diagnostic

This grant opportunity is for Phase I Small Business Innovation Research (SBIR) proposals focused on developing rapid point-of-care (POC) testing for Carbapenem-resistant Acinetobacter baumannii (CRAB). Fast-track proposals and Phase I clinical trials are not accepted. There is only one anticipated award. For Phase I, the budget is up to $243,500 for a duration of up to 6 months. Phase II offe…

Phase I SBIR proposals will be accepted.\nFast-track proposals will not be accepted.\nPhase I clinical trials will not be accepted.\n\nNumber of anticipated awards: 1\n\nBudget (total costs): Phase I up to $243,500 for up to 6 months; Phase II of up to $2,045,816 and a Phase II duration of up to…

Funding Source

Agency: Centers for Disease Control and Prevention
Program: SBIR

Dates

Opportunity Released: August 2, 2024
Open for Submission: August 2, 2024
Application Window Closes: October 18, 2024

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.